Evidence map›Paper›PMID 36362616›Full record

ArticleJournal of clinical medicine2022

Genetic Variability of the Monkeypox Virus Clade IIb B.1.

Fabio Scarpa, Daria Sanna, Ilenia Azzena, Piero Cossu, Chiara Locci, Silvia Angeletti, Antonello Maruotti, Giancarlo Ceccarelli, Marco Casu, Pier Luigi Fiori and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Methods for safely sharing dual-use genetic data.Frontiers in microbiology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. A comprehensive review of monkeypox virus and mpox characteristics.Frontiers in cellular and infection microbiology · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Fabio ScarpaDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-3501-714X
Daria SannaDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-3058-4663
Ilenia AzzenaDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Piero CossuDepartment of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-8946-8261
Chiara LocciDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Silvia AngelettiDepartment of Medicine and Surgery, Unit of Clinical Laboratory Science, University Campus Bio-Medico of Rome, 00128 Rome, Italy.
Antonello MaruottiDepartment GEPLI, Libera Università Ss Maria Assunta, 00193 Rome, Italy.ORCID 0000-0001-8377-9950
Giancarlo CeccarelliDepartment of Public Health and Infectious Diseases, University Hospital Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-5921-3180
Marco CasuDepartment of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-5042-4851
Pier Luigi FioriDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0001-6190-612X
Nicola PetrosilloInfection Prevention and Control, University Hospital Campus Bio-Medico, 00128 Rome, Italy.ORCID 0000-0002-2585-7567
Massimo CiccozziUnit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, 00100 Rome, Italy.ORCID 0000-0003-3866-9239
University of Sassari · ITUniversità Campus Bio-Medico · ITLibera Università Maria SS. Assunta · ITPoliclinico Umberto I · IT

Funding

This research was funded from by FONDAZIONE DI SARDEGNA bando 2022-2023 for the Dipartimento di Scienze Biomediche - UNISS (to Daria Sanna and Fabio Scarpa). NA
6 · The paper itself

Abstract

Monkeypox is caused by a sylvatic, double-stranded DNA zoonotic virus. Since 1 January 2022, monkeypox cases have been reported to WHO from 106 Member States across six WHO regions, and as of 2 October 2022, a total of 68,900 confirmed cases, including 25 deaths, occurred. Here, by using a whole genome approach, we perform a genetic and phylodynamic survey of the monkeypox virus Clade IIb B.1, which is the lineage causing the current multi-country outbreak. Results suggest that outbreaks seem to be isolated and localized in several epidemic clusters with geographic consistency. Currently, monkeypox appears to be a virus with a flattened genetic variability in terms of evolutionary path, with a very slow rate of growth in the population size. This scenario confirms that the monkeypox virus lacks the evolutionary advantage, given by the high level of mutation rate, which is very strong in RNA viruses. Of course, constant genome-based monitoring must be performed over time in order to detect the change in its genetic composition, if any.

Indexed as

epidemiologygenetic diversitylineage B.1monkeypoxorthopoxviruses

Identifiers

PMID36362616
PMCPMC9695420
OpenAlexW4307946518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.